KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cigna (CI) EBITDA (2017 - 2025)

Cigna (CI) has disclosed EBITDA for 9 consecutive years, with $339.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 22.38% to $339.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 billion through Dec 2025, down 35.53% year-over-year, with the annual reading at $1.0 billion for FY2025, 7.5% up from the prior year.
  • EBITDA hit $339.0 million in Q4 2025 for Cigna, up from $233.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $6.8 billion in Q4 2021 to a low of -$5.3 billion in Q4 2023.
  • Historically, EBITDA has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2021.
  • Biggest five-year swings in EBITDA: plummeted 403.6% in 2023 and later surged 714.44% in 2024.
  • Year by year, EBITDA stood at $6.8 billion in 2021, then tumbled by 74.17% to $1.7 billion in 2022, then tumbled by 403.6% to -$5.3 billion in 2023, then surged by 105.22% to $277.0 million in 2024, then increased by 22.38% to $339.0 million in 2025.
  • Business Quant data shows EBITDA for CI at $339.0 million in Q4 2025, $233.0 million in Q3 2025, and $2.3 billion in Q2 2025.